Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine I (Q57396192)
Jump to navigation
Jump to search
article
Language | Label | Description | Also known as |
---|---|---|---|
English | Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine I |
article |
Statements
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF) (English)
Milton Packer
Akshay S Desai
Jim Gong
Martin P Lefkowitz
Adel R Rizkala
Victor C Shi
Scott D Solomon
Karl Swedberg
5 April 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference